24H｜U.S. Pharma Stocks Jump, Tonix up 17%, Novo-Nordisk up 6%; CoreWeave, Core Scientific up 3%

CoreWeave, Inc., Core Scientific, Inc. rose 3% in overnight trading.

U.S. pharma stocks jumped in overnight trading.

Tonix Pharmaceuticals rose 17%; Novo-Nordisk A/S rose 6%; Novavax rose 3%.

Tonix's Tonmya received FDA approval, marking the first new fibromyalgia therapy in 15 years and driving a post-market stock surge.

Tonmya is a non-opioid, once-daily bedtime analgesic with a sublingual formulation designed for rapid absorption.

Fibromyalgia is a chronic pain condition affecting more than 10 million adults in the U.S., predominantly women. The FDA approval was based on two Phase 3 clinical trials involving nearly 1,000 patients, which demonstrated that Tonmya significantly reduced daily pain scores compared to placebo at 14 weeks.